Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

crawled date : 2022 - 02 - 15    crawled time : 08:00    save search

Data Center Accelerators Market revenue to cross USD 25 Bn by 2028: Global Market Insights Inc.
Published: 2022-02-15 (Crawled : 08:00) - prnewswire.com
WDC 4 | $66.04 -3.34% -3.45% 7M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.61% H: 5.18% C: 5.06%
QCOM | $157.65 -2.35% -2.4% 10M twitter stocktwits trandingview |
Electronic Technology
| | O: 2.34% H: 2.93% C: 2.37%
NVDA | $762.01 -10.0% -10.37% 87M twitter stocktwits trandingview |
Electronic Technology
| | O: 2.81% H: 6.4% C: 6.2%
MU F | $106.71 -4.66% -4.89% 34M twitter stocktwits trandingview |
Electronic Technology
| | O: 1.28% H: 6.03% C: 5.48%
INTC | $34.2 -2.4% -2.46% 58M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.25% H: 1.59% C: 1.55%
GOOGL | News S | $154.08 -1.24% -1.25% 32M twitter stocktwits trandingview |
Technology Services
| | O: 1.51% H: 0.39% C: -0.7%
GOOG | News S | $155.7 -1.12% -1.13% 20M twitter stocktwits trandingview |
Technology Services
| | O: 1.6% H: 0.31% C: -0.76%
AMD | $146.54 -5.51% -5.83% 71M twitter stocktwits trandingview |
Electronic Technology
| | O: 2.56% H: 4.0% C: 3.65%

cel market
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2021
Published: 2022-02-15 (Crawled : 08:00) - prnewswire.com
IGMS | $7.2 -2.83% -2.92% 220K twitter stocktwits trandingview |
Health Technology
| | O: 3.23% H: 3.18% C: 0.12%

report
Triazine Market will Record a Year-over-Year Growth of 2.66 in 2022 | 17,000+ Technavio Reports
Published: 2022-02-15 (Crawled : 08:00) - prnewswire.com
ECL | News | $218.16 -0.48% 0.69% 2.6M twitter stocktwits trandingview |
Process Industries
| | O: -0.24% H: 2.0% C: 0.42%
DOW A | $56.66 0.3% -0.03% 3.7M twitter stocktwits trandingview |
Process Industries
| | O: -0.02% H: 1.96% C: 1.71%
ASH | $95.99 0.52% 0.0% 410K twitter stocktwits trandingview |
Process Industries
| | O: 0.77% H: 0.91% C: 0.76%

report growth
Ipsen: Cabometyx® in Combination With Opdivo® Demonstrated Continued Survival and Quality of Life Benefits With Over Two Years of Follow-Up in the Phase III CheckMate -9ER Trial
Published: 2022-02-15 (Crawled : 08:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 0.53% C: 0.46%
EXEL | $22.51 0.09% 0.09% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.86% H: 3.36% C: 2.29%

cabometyx opdivo trial
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.